Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety

Nyan L. Latt,Beshoy Yanny,Derenik Gharibian,Rita Gevorkyan,Amandeep Sahota

Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety

2017

Nyan L. Latt
Beshoy Yanny
Derenik Gharibian
Rita Gevorkyan
Amandeep Sahota

Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naive hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety

Keywords:

Ledipasvir
Hepatitis C virus RNA
Hepatitis C
LEDIPASVIR/SOFOSBUVIR
Single Center
Sofosbuvir
Virology
Genotype
Medicine
Hepacivirus
Viral load
Cirrhosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations